GIACOBBE, DANIELE ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 20.807
AS - Asia 3.573
NA - Nord America 2.367
SA - Sud America 296
AF - Africa 77
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 27.133
Nazione #
IT - Italia 20.228
US - Stati Uniti d'America 2.241
SG - Singapore 1.349
CN - Cina 860
VN - Vietnam 678
BD - Bangladesh 287
FR - Francia 197
BR - Brasile 171
HK - Hong Kong 120
DE - Germania 90
CA - Canada 64
FI - Finlandia 55
GB - Regno Unito 48
JP - Giappone 41
NL - Olanda 41
AR - Argentina 40
IQ - Iraq 37
IN - India 34
MX - Messico 27
ES - Italia 23
ID - Indonesia 22
EC - Ecuador 20
ZA - Sudafrica 19
PH - Filippine 17
TR - Turchia 16
VE - Venezuela 15
CO - Colombia 14
SE - Svezia 14
JO - Giordania 13
PK - Pakistan 12
RU - Federazione Russa 12
PY - Paraguay 11
UA - Ucraina 11
AU - Australia 10
CH - Svizzera 9
CL - Cile 9
EG - Egitto 9
JM - Giamaica 9
NP - Nepal 9
TH - Thailandia 9
UZ - Uzbekistan 9
CR - Costa Rica 8
DZ - Algeria 8
MA - Marocco 8
PE - Perù 8
PL - Polonia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
IE - Irlanda 7
KR - Corea 7
AT - Austria 6
ET - Etiopia 6
PT - Portogallo 6
TN - Tunisia 6
UY - Uruguay 6
BE - Belgio 5
HN - Honduras 5
HU - Ungheria 5
KE - Kenya 5
MY - Malesia 5
RS - Serbia 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LB - Libano 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
GA - Gabon 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
MK - Macedonia 3
MT - Malta 3
OM - Oman 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BO - Bolivia 2
KG - Kirghizistan 2
LT - Lituania 2
MD - Moldavia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
IR - Iran 1
KY - Cayman, isole 1
LK - Sri Lanka 1
Totale 27.121
Città #
Genoa 8.564
Genova 6.926
Vado Ligure 2.159
Rapallo 2.009
Singapore 686
San Jose 607
Ashburn 313
Ho Chi Minh City 212
Lauterbourg 175
Council Bluffs 166
Hanoi 163
New York 151
Beijing 149
Hong Kong 118
Bordighera 78
Santa Clara 66
Frankfurt am Main 65
Helsinki 51
Los Angeles 51
Rome 50
Milan 49
Tokyo 37
Haiphong 34
Buffalo 26
Boardman 25
Da Nang 25
Chicago 21
Orem 18
Toronto 18
Amsterdam 17
Atlanta 17
Biên Hòa 17
Naples 16
Dallas 15
São Paulo 15
Baghdad 14
Bologna 14
Tianjin 14
Amman 13
City of London 13
Guangzhou 13
London 12
Madrid 12
Austin 11
Denver 11
Houston 11
Johannesburg 11
Montreal 11
Phoenix 11
Stockholm 11
Mexico City 10
Paris 10
San Francisco 10
Hải Dương 9
Quito 9
Tashkent 9
Thái Nguyên 9
Zurich 9
Brooklyn 8
Can Tho 8
Kansas City 8
Asunción 7
Bari 7
Curitiba 7
Dhaka 7
Florence 7
Istanbul 7
Jakarta 7
Kyiv 7
Lima 7
Modena 7
The Bronx 7
Addis Ababa 6
Bangkok 6
Berlin 6
Charlotte 6
Chennai 6
Marseille 6
Miami 6
Pasadena 6
Phủ Lý 6
Pozzilli 6
San José 6
Shanghai 6
Shenzhen 6
Suzhou 6
Sydney 6
Turin 6
Venice 6
Verona 6
Warsaw 6
Belgrade 5
Bra 5
Cairo 5
Caracas 5
Catania 5
Dublin 5
Guayaquil 5
Jeddah 5
Mosul 5
Totale 23.626
Nome #
Artificial intelligence and prescription of antibiotic therapy: present and future 415
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 274
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 240
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 232
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 228
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 225
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 221
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 221
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 221
Mould Infections of Traumatic Wounds: A Brief Narrative Review 212
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 204
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 196
Use of colistin in adult patients: a cross-sectional study 195
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 194
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 193
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 193
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 191
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 183
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 182
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 181
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 177
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 176
Bloodstream infections in critically ill patients with COVID-19 175
Management of KPC-producing Klebsiella pneumoniae infections 174
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 174
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 174
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 173
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 172
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 171
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 170
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 170
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 170
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 167
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 167
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 165
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 164
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 158
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 158
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis 158
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 155
Will new antimicrobials overcome resistance among Gram-negatives? 154
Treatment of Infections Due to MDR Gram-Negative Bacteria 151
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 151
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 149
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 149
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 148
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 148
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis 146
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 145
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 144
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 144
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 143
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 143
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 139
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 138
The role of fosfomycin for multidrug-resistant gram-negative infections 138
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 137
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 137
A look at clinical trial design for new antimicrobials for the adult population 137
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 134
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 133
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 133
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 133
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 131
Bloodstream infections in internal medicine 131
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 131
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 131
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies 128
Culture-negative infective endocarditis (CNIE): impact on postoperative mortality 128
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 125
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 123
Ceftolozane/tazobactam: place in therapy 123
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 123
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 122
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 122
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 121
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 121
A NLP Pipeline for the Automatic Extraction of a Complete Microorganism’s Picture from Microbiological Notes 119
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 119
A wide database for future studies aimed at improving early recognition of candidemia 119
Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment 117
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore 116
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 116
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 115
Factors associated with lack of viral suppression at delivery 115
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 114
Ceftobiprole: drug evaluation and place in therapy 113
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 113
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 113
Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia 113
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 112
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 112
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis 112
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 112
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 111
Totale 15.871
Categoria #
all - tutte 105.212
article - articoli 102.310
book - libri 0
conference - conferenze 1.282
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.286
Totale 210.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 0 0 168
2021/20221.858 72 52 93 182 87 134 68 357 223 194 108 288
2022/20232.468 222 207 31 232 294 324 85 161 400 145 303 64
2023/20241.690 80 187 45 216 150 252 142 112 83 77 127 219
2024/20255.696 152 358 157 386 784 580 548 928 240 284 546 733
2025/202610.659 1.262 458 914 727 1.161 637 1.448 666 985 1.079 945 377
Totale 27.855